Braxan | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Clinical Trials
- Clinical Trials
Drugs in Dev.
News
Blog
Market Place
Login

Braxan
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

pharmacompass-2-m-2026-04-20

Braxan

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 10 USDMF, 12 CEP/COS, 2 JDMF, 6 EU WC, 3 KDMF, 5 NDC API, 27 Listed Suppliers

35 API Suppliers
10 USDMF
12 CEP/COS
2 JDMF
6 EU WC
3 KDMF
5 NDC API
27 Listed Suppliers

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

INTERMEDIATES

19 Intermediate Suppliers

19 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

196 FDF Dossiers, 50 FDA Orange Book, 83 Europe, 14 Canada, 6 Australia, 15 South Africa, 28 Listed Dossiers

196 FDF Dossiers
50 FDA Orange Book
83 Europe
14 Canada
6 Australia
15 South Africa
28 Listed Dossiers

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 4 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 4 Kirsch Pharma, 1 Panvo Organics, 1 Cerata Pharmaceuticals LLP, 2 Dr. Paul Lohmann GmbH & Co. KGaA, 6 Actylis, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 12 BASF, 1 CD Formulation, 7 DFE Pharma, 1 Finar, 9 Gangwal Chemicals, 1 Gloria Interchem, 1 Ideal Cures, 4 Ingredion Pharma Solutions, 16 Kerry, 3 Keval Exports, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Pharmachem, 21 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 4 Silverline Chemicals, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 28 Direct Compression, 24 Disintegrants & Superdisintegrants, 24 Granulation, 21 Solubilizers, 19 Thickeners and Stabilizers, 16 Parenteral, 15 Lubricants & Glidants, 14 Co-Processed Excipients, 9 Controlled & Modified Release, 8 Emulsifying Agents, 8 Coating Systems & Additives, 8 Film Formers & Plasticizers, 7 Topical, 7 Chewable & Orodispersible Aids, 7 Taste Masking, 4 API Stability Enhancers, 3 Rheology Modifiers, 3 Surfactant & Foaming Agents, 1 Dry Powder Inhalation

54 Fillers, Diluents & Binders
28 Direct Compression
24 Disintegrants & Superdisintegrants
24 Granulation
21 Solubilizers
19 Thickeners and Stabilizers
16 Parenteral
15 Lubricants & Glidants
14 Co-Processed Excipients
9 Controlled & Modified Release
8 Emulsifying Agents
8 Coating Systems & Additives
8 Film Formers & Plasticizers
7 Topical
7 Chewable & Orodispersible Aids
7 Taste Masking
4 API Stability Enhancers
3 Rheology Modifiers
3 Surfactant & Foaming Agents
1 Dry Powder Inhalation

DIGITAL CONTENT

26 News #PharmaBuzz

26 News #PharmaBuzz

GLOBAL SALES INFORMATION

11 US Medicaid Prescriptions, 27 Regulatory FDF Prices, 3 Annual Reports

11 US Medicaid Prescriptions
27 Regulatory FDF Prices
3 Annual Reports

MARKET PLACE

18 APIs, 22 FDF Dossiers

18 APIs
22 FDF Dossiers

PATENTS & EXCLUSIVITIES

13 US Patents

13 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 USP, 19 Others

3 EDQM
4 USP
19 Others

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

13 All

01 13BAXTER HLTHCARE

filter Patent Number Reset all filters

13 All

01 37635773

02 28410077

03 29200088

04 29493582

05 29750822

06 210177951

API Patent Reset all filters

13 All

01 13Blank

filter FDF Patent Reset all filters

13 All

01 13Y

filter Expiration Date Reset all filters

13 All

01 112029-03-13

02 22033-02-27

Amiodarone Hydrochloride

Product Main Page

01

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

BAXTER HLTHCARE

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

AMIODARONE HYDROCHLORIDE

US Patent Number : 8410077

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

BAXTER HLTHCARE

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-02-27

AMIODARONE HYDROCHLORIDE

US Patent Number : 9493582

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-02-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

BAXTER HLTHCARE

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

AMIODARONE HYDROCHLORIDE

US Patent Number : 9200088

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

BAXTER HLTHCARE

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

AMIODARONE HYDROCHLORIDE

US Patent Number : 10177951

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

BAXTER HLTHCARE

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

AMIODARONE HYDROCHLORIDE

US Patent Number : 7635773

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

BAXTER HLTHCARE

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

AMIODARONE HYDROCHLORIDE

US Patent Number : 7635773

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

BAXTER HLTHCARE

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-02-27

AMIODARONE HYDROCHLORIDE

US Patent Number : 9493582

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-02-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

BAXTER HLTHCARE

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

AMIODARONE HYDROCHLORIDE

US Patent Number : 9200088

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

BAXTER HLTHCARE

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

AMIODARONE HYDROCHLORIDE

US Patent Number : 8410077

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

PEGS Boston Summit

Not Confirmed

BAXTER HLTHCARE

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

AMIODARONE HYDROCHLORIDE

US Patent Number : 9750822

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.